Corporate calendar for Atossa Therapeutics, Inc. (ATOS): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, especially breast cancer, along with other conditions, within the United States. The company's flagship therapeutic candidate is oral (Z)-endoxifen.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 |
Stock Splits
| Date | Ratio |
|---|---|
| 2026-02-02 | 1:15 |
| 2018-04-20 | 1:12 |
| 2016-08-26 | 1:15 |
Price
| Price | $2.42 |
| Market Cap | $24M |
| Exchange | NASDAQ |
| Country | US |
Related companies: CGTX · CLNN · COYA · GLSI · IMMX · ONCY · SRZN
Explore sector: Healthcare · Biotechnology
More sections of ATOS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks